Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Reduction in recurrent renal flares and high-dose corticosteroids in LJP-394-treated lupus patients

Oct. 19, 2001

Hydroxamic acid-based inhibitors of sCD23 formation and TNF processing

Oct. 18, 2001

FDA grant and European OMP designation for Fibrillex

Oct. 18, 2001

ML-3000 spares gastric mucosa in aspirin-treated rats

Oct. 16, 2001

Biochemical studies with etoricoxib in man consistent with GI-sparing antiinflammatory profile

Oct. 16, 2001

Research collaboration established by Sunesis and Chiesi

Oct. 16, 2001

Revotar enters licensing agreement with Fraunhofer Institute for MIF

Oct. 11, 2001

GW-3333: an oral TACE/MMP inhibitor with good activity in chronic arthritis

Oct. 9, 2001

Potent, selective, orally bioavailable aggrecanase inhibitor discovered at DuPont

Oct. 9, 2001

Protalex completes preclinical studies with new arthritis pharmaceutical

Oct. 9, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...